{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:26:09Z","timestamp":1790382369961,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,1,23]],"date-time":"2003-01-23T00:00:00Z","timestamp":1043280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,1,23]],"date-time":"2003-01-23T00:00:00Z","timestamp":1043280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1038\/sj.gt.3301886","type":"journal-article","created":{"date-parts":[[2003,2,5]],"date-time":"2003-02-05T22:32:10Z","timestamp":1044484330000},"page":"251-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines"],"prefix":"10.1038","volume":"10","author":[{"given":"J","family":"Bramson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Dayball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Evelegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y H","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,1,23]]},"reference":[{"key":"BF3301886_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0024-3205(00)00653-6","volume":"67","author":"B Spellberg","year":"2000","unstructured":"Spellberg B . The cutaneous citadel: a holistic view of skin and immunity. Life Sci 2000; 67: 477\u2013502.","journal-title":"Life Sci"},{"key":"BF3301886_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1089\/hum.1997.8.11-1355","volume":"8","author":"Y Wan","year":"1997","unstructured":"Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther 1997; 8: 1355\u20131363.","journal-title":"Hum Gene Ther"},{"key":"BF3301886_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/mthe.2000.0029","volume":"1","author":"MA Perricone","year":"2000","unstructured":"Perricone MA et al. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens. Mol Ther 2000; 1: 275\u2013284.","journal-title":"Mol Ther"},{"key":"BF3301886_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.gt.3300628","volume":"5","author":"P Forg","year":"1998","unstructured":"Forg P, von Hoegen P, Dalemans W, Schirrmacher V . Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 1998; 5: 789\u2013797.","journal-title":"Gene Ther"},{"key":"BF3301886_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/152091599317530","volume":"1","author":"A Smith","year":"1999","unstructured":"Smith A et al. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. Diabetes Technol Therapeutics 1999; 1: 21\u201327.","journal-title":"Diabetes Technol Therapeutics"},{"key":"BF3301886_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","volume":"14","author":"BW Barry","year":"2001","unstructured":"Barry BW . Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101\u2013114.","journal-title":"Eur J Pharm Sci"},{"key":"BF3301886_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.bioeng.2.1.289","volume":"2","author":"DV McAllister","year":"2000","unstructured":"McAllister DV, Allen MG, Prausnitz MR . Microfabricated microneedles for gene and drug delivery. Ann Rev Biomed Eng 2000; 2: 289\u2013313.","journal-title":"Ann Rev Biomed Eng"},{"key":"BF3301886_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/80538","volume":"6","author":"D Chen","year":"2000","unstructured":"Chen D et al. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med 2000; 6: 1187\u20131190.","journal-title":"Nat Med"},{"key":"BF3301886_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S0264-410X(98)00242-4","volume":"17","author":"J Haensler","year":"1999","unstructured":"Haensler J et al. Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 1999; 17: 628\u2013638.","journal-title":"Vaccine"},{"key":"BF3301886_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0264-410X(99)00212-1","volume":"18","author":"A Misra","year":"1999","unstructured":"Misra A, Ganga S, Upadhyay P . Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine 1999; 18: 517\u2013523.","journal-title":"Vaccine"},{"key":"BF3301886_CR11","first-page":"3247","volume":"60","author":"Y Wan","year":"2000","unstructured":"Wan Y et al. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines. Cancer Res 2000; 60: 3247\u20133253.","journal-title":"Cancer Res"},{"key":"BF3301886_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1054-3589(08)60140-4","volume":"40","author":"MM Hitt","year":"1997","unstructured":"Hitt MM, Addison CL, Graham FL . Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 1997; 40: 137\u2013206.","journal-title":"Adv Pharmacol"},{"key":"BF3301886_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/12856","volume":"17","author":"H Fan","year":"1999","unstructured":"Fan H, Lin Q, Morrissey GR, Khavari PA . Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999; 17: 870\u2013872.","journal-title":"Nat Biotechnol"},{"key":"BF3301886_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/41917","volume":"388","author":"DC Tang","year":"1997","unstructured":"Tang DC, Shi Z, Curiel DT . Vaccination onto bare skin. Nature 1997; 388: 729\u2013730.","journal-title":"Nature"},{"key":"BF3301886_CR15","doi-asserted-by":"publisher","first-page":"11\u2009474","DOI":"10.1128\/JVI.75.23.11474-11482.2001","volume":"75","author":"Z Shi","year":"2001","unstructured":"Shi Z et al. Protection against tetanus by needle-free inoculation of adenovirus- vectored nasal and epicutaneous vaccines. J Virol 2001; 75: 11\u2009474\u201311\u2009482.","journal-title":"J Virol"},{"key":"BF3301886_CR16","doi-asserted-by":"crossref","DOI":"10.4324\/9780203483985","volume-title":"Electrically Assisted Transdermal and Topical Drug Delivery","author":"AK Banga","year":"1998","unstructured":"Banga AK . Electrically Assisted Transdermal and Topical Drug Delivery. Taylor & Francis: London, 1998."},{"key":"BF3301886_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1517\/14712598.2.1.75","volume":"2","author":"JL Bramson","year":"2002","unstructured":"Bramson JL, Wan YH . The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen. Expert Opin Biol Ther 2002; 2: 75\u201385.","journal-title":"Expert Opin Biol Ther"},{"key":"BF3301886_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<89::AID-IJC14>3.0.CO;2-I","volume":"86","author":"J Steitz","year":"2000","unstructured":"Steitz J et al. Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 2000; 86: 89\u201394.","journal-title":"Int J Cancer"},{"key":"BF3301886_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","volume":"190","author":"WB Bowne","year":"1999","unstructured":"Bowne WB et al. Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med 1999; 190: 1717\u20131722.","journal-title":"J Exp Med"},{"key":"BF3301886_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/sj.gt.3301521","volume":"8","author":"J Steitz","year":"2001","unstructured":"Steitz J, Bruck J, Knop J, Tuting T . Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Ther 2001; 8: 1255\u20131263.","journal-title":"Gene Ther"},{"key":"BF3301886_CR21","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","volume":"96","author":"WW Overwijk","year":"1999","unstructured":"Overwijk WW et al. Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 1999; 96: 2982\u20132987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301886_CR22","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1073\/pnas.96.10.5340","volume":"96","author":"DM Pardoll","year":"1999","unstructured":"Pardoll DM . Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci USA 1999; 96: 5340\u20135342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301886_CR23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4049\/jimmunol.156.1.224","volume":"156","author":"PW Chen","year":"1996","unstructured":"Chen PW et al. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol 1996; 156: 224\u2013231.","journal-title":"J Immunol"},{"key":"BF3301886_CR24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4049\/jimmunol.156.2.700","volume":"156","author":"Y Zhai","year":"1996","unstructured":"Zhai Y et al. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J Immunol 1996; 156: 700\u2013710.","journal-title":"J Immunol"},{"key":"BF3301886_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/sj.gt.3300668","volume":"5","author":"EA Hirschowitz","year":"1998","unstructured":"Hirschowitz EA et al. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma. Gene Ther 1998; 5: 975\u2013983.","journal-title":"Gene Ther"},{"key":"BF3301886_CR26","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/82225","volume":"6","author":"GM Glenn","year":"2000","unstructured":"Glenn GM et al. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000; 6: 1403\u20131406.","journal-title":"Nat Med"},{"key":"BF3301886_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/36014","volume":"391","author":"GM Glenn","year":"1998","unstructured":"Glenn GM, Rao M, Matyas GR, Alving CR . Skin immunization made possible by cholera toxin. Nature 1998; 391: 851.","journal-title":"Nature"},{"key":"BF3301886_CR28","doi-asserted-by":"publisher","first-page":"11\u2009630","DOI":"10.1128\/JVI.75.23.11630-11640.2001","volume":"75","author":"D Chen","year":"2001","unstructured":"Chen D et al. Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J Virol 2001; 75: 11\u2009630\u201311\u2009640.","journal-title":"J Virol"},{"key":"BF3301886_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/10430340050015590","volume":"11","author":"P Ng","year":"2000","unstructured":"Ng P et al. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum Gene Ther 2000; 11: 693\u2013699.","journal-title":"Hum Gene Ther"},{"key":"BF3301886_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/hum.1996.7.3-333","volume":"7","author":"J Bramson","year":"1996","unstructured":"Bramson J et al. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther 1996; 7: 333\u2013342.","journal-title":"Hum Gene Ther"},{"key":"BF3301886_CR31","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.gt.3300508","volume":"4","author":"JL Bramson","year":"1997","unstructured":"Bramson JL, Hitt M, Gauldie J, Graham FL . Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 1997; 4: 1069\u20131076.","journal-title":"Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301886","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T22:58:45Z","timestamp":1704754725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2,1]]}},"alternative-id":["BF3301886"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301886","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,23]]},"assertion":[{"value":"8 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}